Cerebrospinal fluid detection of interleukin-1β in phase of remission predicts disease progression in multiple sclerosis

BACKGROUND: Absence of clinical and radiological activity in relapsing–remitting multiple sclerosis (RRMS) is perceived as disease remission. We explored the role of persisting inflammation during remission in disease evolution. METHODS: Cerebrospinal fluid (CSF) levels of interleukin 1β (IL-1β), a...

Descripción completa

Detalles Bibliográficos
Autores principales: Rossi, Silvia, Studer, Valeria, Motta, Caterina, Germani, Giorgio, Macchiarulo, Giulia, Buttari, Fabio, Mancino, Raffaele, Castelli, Maura, De Chiara, Valentina, Weiss, Sagit, Martino, Gianvito, Furlan, Roberto, Centonze, Diego
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975953/
https://www.ncbi.nlm.nih.gov/pubmed/24548694
http://dx.doi.org/10.1186/1742-2094-11-32

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975953/
https://www.ncbi.nlm.nih.gov/pubmed/24548694
http://dx.doi.org/10.1186/1742-2094-11-32

Ejemplares similares